François Jean

MedicineBiochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice”.

A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.03.442520

N/A

0DataRank · unranked

17 citations

I. Abrrey Monreal, Sébastien P. Dion, Mason Jager, Antoine Désilets, Andrea D. Olmstead +18 more

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

Nature(2022)10.1038/s41586-022-04661-w

N/A

0DataRank · unranked

233 citations

I. Abrrey Monreal, Sébastien P. Dion, David W. Buchholz, Brian Imbiakha, Andrea D. Olmstead +21 more

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants

Emerging Microbes & Infections(2023)10.1080/22221751.2023.2246594

N/A

0DataRank · unranked

18 citations

L.J. Worrall, Andrea D. Olmstead, Anh‐Tien Ton, Jaeyong Lee, Ivan Villanueva +25 more

Corrigendum to “Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics” “Antiviral Research 209 (2023)/105484”

Antiviral Research(2023)10.1016/j.antiviral.2023.105577

N/A

0DataRank · unranked

0 citations

Tirosh Shapira, Andrea D. Olmstead, Iván Villanueva, Connor A.H. Thompson, Siobhan Ennis +40 more

Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain Resistance

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf294

N/A

0DataRank · unranked

5 citations

Jimena Pérez‐Vargas, Zoë Zhong, Merrilee Thomas, Calem Kenward, W.A. Mosimann +20 more